First real-world analysis of Ebola vaccine reveals 84% effectiveness during Democratic Republic Congo outbreak – Merck Inc
When a deadly outbreak of the Ebola virus spread through the Democratic Republic of Congo in 2018, Merck’s then-unapproved vaccine (Ervebo) was quickly deployed to help address the… read more.